CHANGE IN CONTROL AGREEMENTChange in Control Agreement • March 28th, 2008 • Via Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 28th, 2008 Company Industry JurisdictionTHIS CHANGE IN CONTROL AGREEMENT (this “Agreement”), dated as of January 14, 2008, is made by and between VIA Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Rebecca Taub, M.D. (“Executive”).
CHANGE IN CONTROL AGREEMENTChange in Control Agreement • December 21st, 2007 • Via Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledDecember 21st, 2007 Company Industry JurisdictionTHIS CHANGE IN CONTROL AGREEMENT (this “Agreement”), dated as of December 21, 2007, is made by and between VIA Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Lawrence K. Cohen, Ph.D. (“Executive”).
CHANGE IN CONTROL AGREEMENTChange in Control Agreement • December 21st, 2007 • Via Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledDecember 21st, 2007 Company Industry JurisdictionTHIS CHANGE IN CONTROL AGREEMENT (this “Agreement”), dated as of December 21, 2007, is made by and between VIA Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and James G. Stewart (“Executive”).
CHANGE IN CONTROL AGREEMENTChange in Control Agreement • December 21st, 2007 • Via Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledDecember 21st, 2007 Company Industry JurisdictionTHIS CHANGE IN CONTROL AGREEMENT (this “Agreement”), dated as of December 21, 2007, is made by and between VIA Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Adeoye Olukotun, M.D., (“Executive”).